Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 322 citing Jonas: Intraocular pressure after intravitreal injection of triamcinolone acetonide. (0.33 sec) 

Intravitreal triamcinolone acetonide for exudative age related macular …


JB Jonas, I Kreissig, P Hugger, G Sauder, S … - British Journal of …, 2003 - bjo.bmj.com
Results: Visual acuity increased significantly (p <0.001) from 0.16 (0.11) to a mean maximum
of 0.23 (0.17). Postoperative visual acuity was highest 1–3 months after the injection. 47
(66.2%) eyes gained in maximal visual acuity and 11 (15.5%) eyes lost in visual acuity. ...
Cited by 528 - Related articles - BL Direct - All 11 versions

Intravitreal injection of triamcinolone for diffuse diabetic macular edema


JB Jonas, I Kreissig, A Sofker, RF … - Archives of …, 2003 - archopht.highwire.org
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 442 - Related articles - BL Direct - All 4 versions

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema preliminary …


P Massin, F Audren, B Haouchine, A Erginay, JF … - Ophthalmology, 2004 - Elsevier
Cited by 294 - Related articles - All 11 versions

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

- occhioallaretina.it [PDF] 
JB Jonas, RF Degenring, I Kreissig, I Akkoyun, BA … - Ophthalmology, 2005 - Elsevier
The study included 272 patients (305 eyes) receiving an intravitreal injection of approximately
20 mg triamcinolone acetonide as treatment for diffuse diabetic macular edema (n = 84
patients), exudative age-related macular degeneration (n = 181 patients), retinal vein ...
Cited by 168 - Related articles - All 4 versions

Intravitreal triamcinolone acetonide and intraocular pressure


LM Smithen, MD Ober, L Maranan, RF Spaide - American journal of …, 2004 - Elsevier
There were 89 patients with a mean age of 76.4 years. The mean baseline IOP was 14.9 mm
Hg with a mean change of 8.0 mm Hg. Thirty-six patients (40.4%) experienced a pressure elevation
to 24 mm Hg or higher at a mean of 100.6 days (SD = 83.1 day) after treatment. Of ...
Cited by 126 - Related articles - All 11 versions

Verteporfin therapy combined with intravitreal triamcinolone in all types of …


AJ Augustin, U Schmidt-Erfurth - Ophthalmology, 2006 - Elsevier
Cited by 114 - Related articles - All 10 versions

SDF-1 is both necessary and sufficient to promote proliferative retinopathy

- nih.gov
JM Butler, SM Guthrie, M Koc, A Afzal, S … - Journal of Clinical …, 2005 - Am Soc Clin Investig
Diabetic retinopathy is the leading cause of blindness in working-age adults. It is caused by oxygen
starvation in the retina inducing aberrant formation of blood vessels that destroy retinal
architecture. In humans, vitreal stromal cell–derived factor–1 (SDF-1) concentration ...
Cited by 113 - Related articles - All 9 versions

Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema


JB Jonas, I Kreissig, RF Degenring - American journal of ophthalmology, 2003 - Elsevier
In the follow-up period of 6.6 ± 4.1 months, visual acuity increased from 0.26 ± 0.13 to a mean
maximal visual acuity of 0.60 ± 0.19. For all patients, visual acuity improved during the
follow-up by at least 0.20. Two (40%) patients developed intraocular pressure values ...
Cited by 104 - Related articles - All 10 versions

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and …


JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - duanesolution.com
Cited by 89 - Related articles - BL Direct - All 5 versions

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult …


AJ Augustin, U Schmidt-Erfurth - American journal of ophthalmology, 2006 - Elsevier
The mean number of treatments needed was 1.8. Thirty-four eyes (82.9%) required one retreatment
at three months. No additional retreatments were necessary. Visual acuity improved gradually
in most of the patients with mean values of 20/133 and 20/115 at baseline and three ...
Cited by 80 - Related articles - All 20 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google